(ALX) Alexanders - Overview
Stock: Office, Retail, Residential, Mixed-Use, REIT
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 8.40% |
| Yield on Cost 5y | 9.91% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 32.2% |
| Payout Ratio | 3.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 47.1% |
| Relative Tail Risk | 0.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | 17.22 |
| Character TTM | |
|---|---|
| Beta | 0.358 |
| Beta Downside | 0.459 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.80% |
| CAGR/Max DD | 0.26 |
Description: ALX Alexanders January 19, 2026
Alexander & Co., Inc. (NYSE: ALX) is a retail-focused REIT that owns and operates five properties in the New York City metro area, including the 731 Lexington Avenue office-retail tower (home to Bloomberg L.P.’s headquarters), the Rego Center retail complex in Queens (Rego Park I & II), the Alexander residential tower, and a retail asset in Flushing, NY. All properties are managed by Vornado Realty Trust, which also serves as ALX’s external manager.
Key performance indicators as of the latest 10-K (Q4 2023) show a weighted-average lease-expiry of 5.2 years and an occupancy rate of roughly 93 %, with annualized funds-from-operations (FFO) of $0.61 per share, reflecting modest growth versus the prior year’s $0.57 per share. The REIT’s leverage stands at a net debt-to-FFO ratio of 5.8×, slightly above the sector median of ~5.0×, indicating higher financial risk.
Sector drivers that materially affect ALX include the outlook for NYC office demand-still pressured by hybrid work trends-and the resilience of suburban-to-urban retail foot traffic, which benefits the Rego Center locations. Additionally, New York’s commercial real-estate tax reforms and potential rent-stabilization policy changes represent macro-level uncertainties that could impact net operating income.
For investors seeking a deeper quantitative dive, ValueRay’s platform offers a granular, data-rich view of ALX’s cash-flow sensitivity to lease-renewal risk and interest-rate shifts-worth a look before forming a position.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: error (cannot be calculated; needs Net Income TTM and Revenue TTM) |
| FCF/TA: 0.34 > 0.02 and ΔFCF/TA 29.00 > 1.0 |
| NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA 0.34 > 3% & CFO 80.8m > Net Income 28.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 5.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (5.14m) vs 12m ago 0.06% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 0.0% > 50% (prev 16.88%; Δ -16.88% > 0%) |
| Interest Coverage Ratio: -0.45 > 6 (EBITDA TTM -35.1m / Interest Expense TTM -51.6m) |
Altman Z'' 6.13
| A: 0.81 (Total Current Assets 237.2m - Total Current Liabilities 45.5m) / Total Assets 237.2m |
| B: 0.29 (Retained Earnings 69.2m / Total Assets 237.2m) |
| C: -0.03 (EBIT TTM -23.4m / Avg Total Assets 789.3m) |
| D: 0.07 (Book Value of Equity 69.2m / Total Liabilities 1.00b) |
| Altman-Z'' Score: 6.13 = AAA |
What is the price of ALX shares?
Over the past week, the price has changed by -7.89%, over one month by -0.84%, over three months by +1.86% and over the past year by +28.32%.
Is ALX a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 0
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the ALX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 190 | -16.2% |
| Analysts Target Price | 190 | -16.2% |
| ValueRay Target Price | 259.5 | 14.4% |
ALX Fundamental Data Overview February 10, 2026
P/S = 6.0356
P/B = 10.1516
Revenue TTM = 0.0 USD
EBIT TTM = -23.4m USD
EBITDA TTM = -35.1m USD
Long Term Debt = 987.1m USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 1.10b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -128.2m USD (from netDebt column, last fiscal year)
Enterprise Value = 2.28b USD (1.30b + Debt 1.10b - CCE 128.2m)
Interest Coverage Ratio = -0.45 (Ebit TTM -23.4m / Interest Expense TTM -51.6m)
EV/FCF = 28.15x (Enterprise Value 2.28b / FCF TTM 80.8m)
FCF Yield = 3.55% (FCF TTM 80.8m / Enterprise Value 2.28b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 60.8m) / Revenue TTM)
Tobins Q-Ratio = 9.59 (Enterprise Value 2.28b / Total Assets 237.2m)
Interest Expense / Debt = -8.11% (Interest Expense -89.3m / Debt 1.10b)
Taxrate = 21.0% (US default 21%)
NOPAT = -18.5m (EBIT -23.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 5.22 (Total Current Assets 237.2m / Total Current Liabilities 45.5m)
Debt / Equity = 10.08 (Debt 1.10b / totalStockholderEquity, last fiscal year 109.2m)
Debt / EBITDA = 3.66 (negative EBITDA) (Net Debt -128.2m / EBITDA -35.1m)
Debt / FCF = -1.59 (Net Debt -128.2m / FCF TTM 80.8m)
Total Stockholder Equity = 153.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.58% (Net Income 28.2m / Total Assets 237.2m)
RoE = 18.40% (Net Income TTM 28.2m / Total Stockholder Equity 153.4m)
RoCE = -2.05% (EBIT -23.4m / Capital Employed (Equity 153.4m + L.T.Debt 987.1m))
RoIC = -1.63% (negative operating profit) (NOPAT -18.5m / Invested Capital 1.13b)
WACC = 3.92% (E(1.30b)/V(2.40b) * Re(7.23%) + (debt cost/tax rate unavailable))
Discount Rate = 7.23% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.04%
[DCF Debug] Terminal Value 85.55% ; FCFF base≈75.7m ; Y1≈70.2m ; Y5≈63.9m
Fair Price DCF = 402.0 (EV 1.92b - Net Debt -128.2m = Equity 2.05b / Shares 5.11m; r=5.90% [WACC]; 5y FCF grow -9.17% → 2.90% )
EPS Correlation: -83.10 | EPS CAGR: -54.26% | SUE: 0.0 | # QB: 0
Revenue Correlation: -41.28 | Revenue CAGR: -62.59% | SUE: 0.03 | # QB: 0